The ECTRIMS annual Winter School is aimed at supporting timely international scientific/clinical meetings on topics of interest and importance in multiple sclerosis. Programmes are limited in the number of participants and are held in European locations designed to facilitate discussion and interaction. Outcomes from the programme are often published in an internationally recognised journal.
APPLICATION DEADLINE: Monday, 9 September 2024 (CEST 23:59)
The 3rd ECTRIMS Winter School is recommended for young clinicians specialising in multiple sclerosis as well as for neurology fellows, who are eager to understand the novel diagnostic criteria for MS.
The Winter School aims to present and critically discuss the 2024 McDonald criteria for the diagnosis for MS. We will cover the role of optic nerve MRI, optical coherence tomography and novel imaging, and fluid biomarkers in the revised criteria. Each novel recommendation will be presented in light of the current literature, and practical considerations will be made to facilitate the introduction of the novel criteria in clinical practice. The workshop will also discuss diagnostic challenges and help participants understand how to apply the novel diagnostic criteria in specific MS patients.
____________________________________
Required documents for the application:
For successful applicants, the following costs will be covered:
Results about acceptance will be sent out by the beginning of October 2024.
The 2nd ECTRIMS Winter School was directed towards young clinicians specialising in multiple sclerosis – neurologists, researchers, residents, and fellows – who are eager to deepen their understanding of biomarkers and their applications in MS.
The Winter School provided a comprehensive understanding of cerebrospinal fluid (CSF) and blood biomarkers for MS differential diagnosis, for monitoring disease activity as well as progression, and for predicting treatment response. Participants gained insights from renowned experts in the field of MS research and biomarkers to broaden their understanding of biomarker discovery, validation, and clinical applications in MS.
The Winter School also included practical workshops, including on statistics, to help better identify, analyse, and interpret biomarkers in MS. These sessions provided a unique opportunity to collaborate and learn from fellow young clinicians and experts in the field.
The first annual ECTRIMS Winter School – jointly organised with Magnetic Resonance Imaging in Multiple Sclerosis (MAGNIMS) – was directed towards young MS clinicians and investigators with an interest in diagnosis and management of multiple sclerosis, as well as MS research including magnetic resonance imaging (MRI) techniques. MRI plays a key role in the diagnosis and management of people with multiple sclerosis. Appropriate knowledge and expertise in the use of MRI for MS clinical assessment as well as research is central in the career development of any MS expert.
The course aimed to equip participants with the knowledge and expertise needed to diagnose MS, evaluate the effectiveness of drugs in MS, understand the value of non-conventional and quantitative MRI for assessing structural, metabolic and functional damage in MS, and become familiar with the different techniques used for imaging analysis.